DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fosaprepitant
Fosaprepitant
CP.PMN.158 Netupitant and Palonosetron (Akynzeo)
Fosaprepitant Dimeglumine (Emend® for Injection) Prior Authorization Drug Coverage Policy
MASCC/ESMO ANTIEMETIC GUIDELINE 2016 with Updates in 2019
Emend® (Fosaprepitant Dimeglumine)
Deciphering Emesis
HHS Template for Reports, with Instructions
The Effect of Intravenous Maropitant on Blood Pressure in Healthy Awake and Anesthetized Dogs
Safety of HTX-019 (Intravenous Aprepitant) and Fosaprepitant in Healthy Subjects
Rolapitant in the Current Management of Chemotherapy-Induced Nausea and Vomiting
( 12 ) United States Patent
Beschlussfassung Der 7. Sitzung Der Arbeitsgruppe ATC/DDD Am 28.11
The Significance of NK1 Receptor Ligands and Their Application In
Human Acute Myeloid Leukemia Cells Express Neurokinin-1 Receptor, Which Is Involved in the Antileukemic Effect of Neurokinin-1 Receptor Antagonists
Estonian Statistics on Medicines 2016 1/41
FOSAPREPITANT for INJECTIION S.No. Category Question Answer
ASCO's Antiemetics Drug, Dose, and Schedule Table
Changes Highlighted Final Version Date of Issue: 23Rd December 2015
CDR Clinical Review Report for Akynzeo
Top View
(12) United States Patent (10) Patent No.: US 9.446,029 B2 Boscan Et Al
Lääkealan Turvallisuus- Ja Kehittämiskeskuksen Päätös
Estonian Statistics on Medicines 2013 1/44
Effects of Rolapitant on Nausea/Vomiting in Patients With
Drug Review: Fosaprepitant
Neurokinin-1 (NK1) Receptor Antagonists and Combinations
Spotlight on the Perioperative Use of Maropitant Citrate Bonnie L
Phase II Study of Fosaprepitant + 5HT3 Receptor Antagonist +
List of Psychoactive Drug Spirits for MD A-Methylfentanyl, Abilify
EMEND (Aprepitant and Fosaprepitant) RATIONALE FOR
2013 National Hospital Ambulatory Medical Care Survey Emergency
Responding to the Challenge of Chemotherapy-Induced Nausea and Vomiting
Pilot Study Evaluating MK-869 for Prevention of Nausea and Vomiting
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahr 2020
Akynzeo Injection (Fosnetupitant Palonosetron), Cinvanti, Emend (Aprepitant), Emend Injection (Fosaprepitant), Varubi (Rolapitant)
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0231688 A1
IVEMEND, INN-Fosaprepitant Dimeglumine
Neurokinin-1 Receptor Antagonists in Preventing Postoperative Nausea and Vomiting a Systematic Review and Meta-Analysis